The pharmacokinetics and pharmacodynamics of subcutaneously administered vessel dilator peptide in stable patients with chronic heart failure and moderate renal impairment.
Latest Information Update: 16 Jul 2019
At a glance
- Drugs Atrial-natriuretic-factor-prohormone-31-67 (Primary)
- Indications Chronic heart failure
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Madeleine Pharmaceuticals
- 31 May 2012 New trial record